Building on a nearly two-decade partnership with Hospital for Special Surgery (HSS), SNF is helping the world-leading orthopedics institution expand and modernize its facilities.
A new grant from SNF will support the construction of the new Anna-Maria and Stephen Kellen Tower, which will expand space for HSS joint replacement and spine care. Part of a larger transformation of its campus, the creation of the new Kellen Tower will help HSS better serve patients’ musculoskeletal health needs and advance clinical research that aims to raise the standard of care available to all.
A Digital Inpatient Experience spanning three floors of the new building, including patient rooms equipped with state-of-the-art technology for optimal care and recovery, will be named for SNF.
HSS performs more than 38,400 surgeries and handles 1 million outpatient visits each year. In addition to setting standards through care and research, education is a core component of its mission. HSS reaches over 44,000 medical professionals in scores of countries annually through education and training initiatives. The HSS-Stavros Niarchos Foundation Orthopedic Seminar Program, for instance, formed a long-term bridge of knowledge exchange between Greece and New York, with surgeons honing new skills through case presentations and hands-on practice at HSS to improve the care they deliver back home.
The new 12-story, 94,000-square-foot Kellen Tower will be located on the east side of Manhattan atop the bustling FDR drive, and will include an imaging center, examination rooms, inpatient facilities, and space for collaborative academic training and research to take place.
The tower will also become the new home of the SNF Complex Joint Reconstruction Center (CJRC). The SNF CJRC specializes in care of and research in the most challenging cases in the already demanding field of joint replacement, centralizing the world-class resources of HSS to create a one-stop experience that improves patient outcomes.
The Kellen Tower is expected to open and begin serving patients in 2025.